ArticleCells2026
Adipocyte
Minghui Qin, Fuqiang Li, Mingjie Yang, Lai Wang, Behrooz G Sharifi, Prediman K Shah
Abstract read
In one paragraphArticle in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Minghui QinThe Oppenheimer Atherosclerosis Research Center, Cedars Sinai Heart Institute Cedars-Sinai Med. Ctr., Los Angeles, CA 90048, USA.
Fuqiang LiThe Oppenheimer Atherosclerosis Research Center, Cedars Sinai Heart Institute Cedars-Sinai Med. Ctr., Los Angeles, CA 90048, USA.
Mingjie YangThe Oppenheimer Atherosclerosis Research Center, Cedars Sinai Heart Institute Cedars-Sinai Med. Ctr., Los Angeles, CA 90048, USA.
Lai WangThe Oppenheimer Atherosclerosis Research Center, Cedars Sinai Heart Institute Cedars-Sinai Med. Ctr., Los Angeles, CA 90048, USA.
Behrooz G SharifiThe Oppenheimer Atherosclerosis Research Center, Cedars Sinai Heart Institute Cedars-Sinai Med. Ctr., Los Angeles, CA 90048, USA.ORCID 0000-0002-3877-5907 Prediman K ShahThe Oppenheimer Atherosclerosis Research Center, Cedars Sinai Heart Institute Cedars-Sinai Med. Ctr., Los Angeles, CA 90048, USA.
Funding
A hypercholesterolemia-induced immunometabolite in atherosclerosisR01HL160860 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI SHAH, PREDIMAN KRISHAN · 2022 to 2025
$2.5MThe role of GATA3-positive macrophages in cardiovascular pathologiesR01HL160908 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI SHAH, PREDIMAN KRISHAN · 2022 to 2025
$1.7MNational Heart Lung and Blood Institute R01HL160860 and R01HL160908 (to P.K.S.)NHLBI NIH HHS R01 HL160860NHLBI NIH HHS R01 HL160908
6 · The paper itselfAbstract
Adipose tissue dysfunction drives obesity-associated metabolic disease, yet the transcriptional regulators of pathological adipose remodeling remain undefined. Here, we identify adipocyte
Indexed as
AdipocytesAdipose TissueGATA3 Transcription FactorMetabolic DiseasesAdipogenesisAnimalsDiet, High-FatHumansMaleMiceMice, Inbred C57BLObesityGata3 protein, mouseGATA3 Transcription Factoradipocytechemokinediet-inducible regulatorGata3inflammationobesity
Identifiers
PMID42782745
PMCPMC13605690
What OpenQuestion holds
Textmetadata
Read underepoch 390